Publication for HLA-A and PSMB8

Species	Symbol	Function*	Entrez Gene ID*	Other ID	Gene coexpression	CoexViewer
hsa	HLA-A	major histocompatibility complex, class I, A	3105			[link]
hsa	PSMB8	proteasome 20S subunit beta 8	5696

Pubmed ID	Priority	Text
17316446	0.92	HLA A: 1 - 4th exon 7(C), 2 - 5th exon 3 (GGA); HLA - B: 3(GA) & 3(CA);beta2m: 1 - 1st exon 4(CT), 2 - 2nd exon 4(GA) & 5(A), 3 - 2nd exon 5(A); TAP1: 1 - 1st exon 5(C), 2 - 3rd exon 5(T), 3 - 8th exon 5(G), 4 - 10th exon 5(G), 5 - 11th exon 6(G) & 5(A); TAP2: 1 - 2nd exon 6(C), 2 - 9th exon 5(G); Tapasin: 1 - 2nd exon 5(G), 2 - 3rd exon 5(C), 3 - 4th exon 6(C), 4 - 5th exon 5(G); Calnexin: 1 - 7th exon 5(A), 2 - 8th exon 5(A), 3 - 11th exon 8(T); Calreticulin: 1 - 3rd exon 5(G), 6th exon 5(C); ERp57: 1 - 5th exon 6(T), 2 - 6th exon 6(A), 3 - 13th exon 6(C); LMP2: 1 - 2nd exon 5(G), 2 - 6th exon 5(G); LMP7: 1st exon 6(C) (key: ins - insertion; del - deletion; 0 - no mutation).
31767055	0.91	PSMB8, PSMB9, PSMB10, TAP1, TAP2, ERAP1, ERAP2, CANX, CALR, PDIA3, TAPBP, B2M, HLA-A, HLA-B and HLA-C (Figure 1:source data 1).
22588558	0.87	HLA-A, TAP2, LMP7 and tapasin were down-regulated in NPC compared with control tissues.
	0.86	LMP7 (P<0.001), TAP1 (P<0.001), tapasin (P=0.019) and HLA-A (P<0.001) was observed in NPC.
28536458	0.86	HLA-A, beta2m, TAP1, TAP2, LMP2 and LMP7; beta-tubulin served as loading control.
	0.78	HLA-A, B2M, TAP1, TAP2, LMP2 and LMP7.
	0.67	HLA-A (black), B2M (grey), TAP1 (light blue), TAP2 (dark blue), LMP2 (light green) and LMP7 (dark green) in 4 MCC cell lines was determined by RT-qPCR in triplicates using specific primers; CT values were normalized to RPLP0 and calibrated to a set of DeltaCTs of MKL-2; relative mRNA expression is depicted as mean + SEM.
	0.53	HLA-A, B2M, TAP1, TAP2, LMP2 and LMP7 was determined by RT-qPCR in triplicates; CT values were normalized to RPLP0 and calibrated to the DeltaCT value of untreated MKL-2 cells; relative mRNA expression is depicted + SEM for MKL-2, BroLi, MKL-1 and WaGa.
27467256	0.83	HLA-A, Calr, TAP1&2, PSMB9, PSMB8, TAPBP) and class II antigen presenting pathway (HLA-DR, LAMP2, HLA-DM, HLA-DO, and CD74) (Fig 6D and 6E), and inflammation such as IL-6 and STAT3, and several positive regulators of transcription factors involved in IFNgamma signaling pathway (STAT1, IRF9) (Fig 6F) compared to PD-L1low lung cancer cell lines.
23024775	0.82	LMP7), endoplasmic reticulum aminopeptidase 1(ERAP1), chaperone molecules include calreticulin (CLR), calnexin (CNX) and ERp57, and this was proved again by analysis of transcription of the same genes in addition to three genes HLA-A, B and C coding for HLA-I. By bisulfite sequencing approach, we identified target CpG islands methylated at the gene promoter region of TAP1, TAP2, LMP7, tapasin and ERp57 in cervical carcinoma cells.
27264839	0.80	HLA-A and HLA-B (3% respectively) and PSMB7 (LMP7, 3%).
	0.64	HLA-A, HLA-B, TAP2 and LMP7 the most frequently mutated genes (4%, respectively).
	0.62	LMP7, LMP10, TAP1, TAP2, Tapasin, Calreticulin, Calnexin, ERp57, beta2-microglobulin) and HLA class I loci (HLA-A, HLA-B and HLA-C).
28622390	0.80	HLA-A, HLA-B, and HLA-C), but also immune proteasome subunits and ER transporters involved in antigen processing prior to presentation (PSMB8, PSMB9, and TAP1).
28718425	0.73	HLA-A, HLA-B, HLA-C, beta 2m, LMP2, LMP7 and TAP1.